- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- FUC- NAG- FUC: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-FUC-NAG-FUC.4: 7 residues within 4Å:- Chain A: N.164, N.165
- Chain C: Y.351, A.352, L.452, T.470, F.490
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.470, C:T.470
NAG-FUC-NAG-FUC.8: 5 residues within 4Å:- Chain A: Y.351, A.352, T.470
- Chain B: N.164, N.165
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.470, A:T.470
NAG-FUC-NAG-FUC.12: 4 residues within 4Å:- Chain B: Y.351, T.470
- Chain C: N.164, N.165
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.470, B:T.470
- 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: N.122, T.124, N.125, E.154
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: G.339, N.343, L.368, S.371
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: N.616, Q.644
- Chain B: I.834
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: H.146, N.148, N.149
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.709, N.710, G.1131
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: N.1098, T.1100, H.1101, F.1103
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.1134
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: C.15, N.17, N.137
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain B: N.122, T.124, N.125, E.154
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain B: G.339, N.343, L.368, S.371
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain B: N.616, Q.644
- Chain C: I.834
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain B: H.146, N.148, N.149
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.709, N.710, G.1131
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain B: N.1098, T.1100, H.1101, F.1103
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.1134
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: C.15, N.17, N.137
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: N.122, T.124, N.125, E.154
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: G.339, N.343, L.368, S.371
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain A: I.834
- Chain C: N.616, Q.644
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: H.146, N.148, N.149
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: N.709, N.710, G.1131
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain C: N.1098, T.1100, H.1101, F.1103
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.1134
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain C: C.15, N.17, N.137
Ligand excluded by PLIP- 3 x GE9: 2,3,5-tris(iodanyl)benzamide(Non-covalent)
GE9.25: 5 residues within 4Å:- Chain A: Y.660, S.673, Q.675, I.693, Y.695
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Q.675
- Hydrogen bonds: A:S.673
- pi-Stacking: A:Y.660
GE9.40: 5 residues within 4Å:- Chain B: Y.660, S.673, Q.675, I.693, Y.695
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:Q.675
- Hydrogen bonds: B:S.673
- pi-Stacking: B:Y.660
GE9.56: 5 residues within 4Å:- Chain C: Y.660, S.673, Q.675, I.693, Y.695
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:Q.675
- Hydrogen bonds: C:S.673
- pi-Stacking: C:Y.660
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
SIA.26: 8 residues within 4Å:- Chain A: Y.145, W.152, G.181, Q.183, H.245, S.247, L.249, T.259
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.152, A:H.245, A:T.259
- Hydrogen bonds: A:Y.145, A:Q.183, A:S.247
SIA.41: 8 residues within 4Å:- Chain B: Y.145, W.152, G.181, Q.183, H.245, S.247, L.249, T.259
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:W.152, B:H.245, B:T.259
- Hydrogen bonds: B:Y.145, B:Q.183, B:S.247
SIA.57: 8 residues within 4Å:- Chain C: Y.145, W.152, G.181, Q.183, H.245, S.247, L.249, T.259
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:W.152, C:H.245, C:T.259
- Hydrogen bonds: C:Y.145, C:Q.183, C:S.247
- 3 x EIC: LINOLEIC ACID(Non-covalent)
EIC.27: 16 residues within 4Å:- Chain A: R.408, Q.409, G.416
- Chain B: P.337, F.338, V.341, A.363, Y.365, Y.369, F.374, F.377, L.387, F.392, V.395, L.513, F.515
17 PLIP interactions:15 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.338, B:F.338, B:V.341, B:Y.365, B:Y.365, B:Y.369, B:F.374, B:F.374, B:F.377, B:F.377, B:L.387, B:F.392, B:F.392, B:L.513, B:F.515
- Water bridges: A:K.417
- Salt bridges: A:R.408
EIC.42: 16 residues within 4Å:- Chain B: R.408, Q.409, G.416
- Chain C: P.337, F.338, V.341, A.363, Y.365, Y.369, F.374, F.377, L.387, F.392, V.395, L.513, F.515
17 PLIP interactions:15 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:F.338, C:F.338, C:V.341, C:Y.365, C:Y.365, C:Y.369, C:F.374, C:F.374, C:F.377, C:F.377, C:L.387, C:F.392, C:F.392, C:L.513, C:F.515
- Water bridges: B:K.417
- Salt bridges: B:R.408
EIC.43: 15 residues within 4Å:- Chain A: P.337, F.338, V.341, A.363, Y.365, Y.369, F.374, F.377, L.387, F.392, V.395, L.513, F.515
- Chain C: R.408, Q.409
18 PLIP interactions:3 interactions with chain C, 15 interactions with chain A- Hydrogen bonds: C:Q.409
- Water bridges: C:K.417
- Salt bridges: C:R.408
- Hydrophobic interactions: A:F.338, A:F.338, A:V.341, A:Y.365, A:Y.365, A:Y.369, A:F.374, A:F.374, A:F.377, A:F.377, A:L.387, A:F.392, A:F.392, A:L.513, A:F.515
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Buchanan, C.J. et al., Pathogen-sugar interactions revealed by universal saturation transfer analysis. Science (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- FUC- NAG- FUC: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)][alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 36 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x GE9: 2,3,5-tris(iodanyl)benzamide(Non-covalent)
- 3 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Buchanan, C.J. et al., Pathogen-sugar interactions revealed by universal saturation transfer analysis. Science (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein,Fibritin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C